LTHM Stock Overview
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$29.22|
|52 Week High||US$33.04|
|52 Week Low||US$16.75|
|1 Month Change||30.74%|
|3 Month Change||39.08%|
|1 Year Change||62.33%|
|3 Year Change||341.39%|
|5 Year Change||n/a|
|Change since IPO||72.19%|
Recent News & Updates
New Forecasts: Here's What Analysts Think The Future Holds For Livent Corporation (NYSE:LTHM)
Celebrations may be in order for Livent Corporation ( NYSE:LTHM ) shareholders, with the analysts delivering a...
Lithium Rush: It's High Time To Buy Livent
The lithium market will remain in a deficit until 2024 due to high demand from auto manufacturers. Due to acceleration in the adaptation of cars to new sources of energy, demand for batteries will increase. High demand for batteries will generate around 80% of demand for lithium as early as 2025, compared to 60% in 2019. Persistent high price of raw materials creates a favorable economic environment for lithium feedstock producers such as Livent, which is our favorite.
|LTHM||US Chemicals||US Market|
Return vs Industry: LTHM exceeded the US Chemicals industry which returned -3.4% over the past year.
Return vs Market: LTHM exceeded the US Market which returned -12.3% over the past year.
|LTHM Average Weekly Movement||13.3%|
|Chemicals Industry Average Movement||7.1%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: LTHM is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: LTHM's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds.
Livent Fundamentals Summary
|LTHM fundamental statistics|
Is LTHM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LTHM income statement (TTM)|
|Cost of Revenue||US$332.10m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.34|
|Net Profit Margin||11.56%|
How did LTHM perform over the long term?See historical performance and comparison
Is Livent undervalued compared to its fair value and its price relative to the market?
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LTHM ($29.22) is trading below our estimate of fair value ($91.64)
Significantly Below Fair Value: LTHM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: LTHM is poor value based on its Price-To-Earnings Ratio (86.5x) compared to the US Chemicals industry average (16.9x).
PE vs Market: LTHM is poor value based on its Price-To-Earnings Ratio (86.5x) compared to the US market (15.1x).
Price to Earnings Growth Ratio
PEG Ratio: LTHM is poor value based on its PEG Ratio (4.4x)
Price to Book Ratio
PB vs Industry: LTHM is overvalued based on its Price-To-Book Ratio (5.6x) compared to the US Chemicals industry average (2.3x).
How is Livent forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LTHM's forecast earnings growth (19.5% per year) is above the savings rate (1.9%).
Earnings vs Market: LTHM's earnings (19.5% per year) are forecast to grow faster than the US market (12.3% per year).
High Growth Earnings: LTHM's earnings are forecast to grow, but not significantly.
Revenue vs Market: LTHM's revenue (16.2% per year) is forecast to grow faster than the US market (7.8% per year).
High Growth Revenue: LTHM's revenue (16.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LTHM's Return on Equity is forecast to be low in 3 years time (18.7%).
How has Livent performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LTHM has a high level of non-cash earnings.
Growing Profit Margin: LTHM became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: LTHM's earnings have declined by 48.7% per year over the past 5 years.
Accelerating Growth: LTHM has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: LTHM has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (30.2%).
Return on Equity
High ROE: LTHM's Return on Equity (6.4%) is considered low.
How is Livent's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: LTHM's short term assets ($364.5M) exceed its short term liabilities ($120.3M).
Long Term Liabilities: LTHM's short term assets ($364.5M) exceed its long term liabilities ($273.3M).
Debt to Equity History and Analysis
Debt Level: LTHM's net debt to equity ratio (20.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if LTHM's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: LTHM's debt is not well covered by operating cash flow (10.2%).
Interest Coverage: Insufficient data to determine if LTHM's interest payments on its debt are well covered by EBIT.
What is Livent current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LTHM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LTHM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LTHM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LTHM's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LTHM has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Paul Graves (49 yo)
Mr. Paul W. Graves has been President, Chief Executive Officer & Director of Livent Corporation since May 2018. Mr. Graves serves as an Independent Director at Lydall Inc. since April 20, 2021. Mr. Graves...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD4.75M) is below average for companies of similar size in the US market ($USD6.83M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
Experienced Management: LTHM's management team is considered experienced (3.8 years average tenure).
Experienced Board: LTHM's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.3%.
Livent Corporation's employee growth, exchange listings and data sources
- Name: Livent Corporation
- Ticker: LTHM
- Exchange: NYSE
- Founded: 2018
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: US$4.723b
- Shares outstanding: 161.64m
- Website: https://livent.com
Number of Employees
- Livent Corporation
- 1818 Market Street
- Suite 2550
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/24 00:00|
|End of Day Share Price||2022/05/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.